Conmed (CNMD) FCF Margin (2010 - 2026)

Conmed's FCF Margin history runs 17 years deep, the most recent figure standing at 3.34% for Q1 2026.

• Quarterly FCF Margin fell 842.0% year-over-year to 3.34% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.03% (down 348.0% YoY) and the FY2025 annual result came in at 10.98%, down 80.0% from the prior year.
• FCF Margin was 3.34% for Q1 2026 at Conmed, down from 11.05% in the prior quarter.
• Across five years, FCF Margin topped out at 15.76% in Q4 2023 and bottomed at 6.89% in Q4 2022.
• A 5-year average of 7.72% and a median of 8.67% in 2024 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2022 — FCF Margin tumbled 1805 bps — and 2023, when it soared 2265 bps.
• Conmed's FCF Margin stood at 6.89% in 2022, then surged by 329 bps to 15.76% in 2023, then decreased by 28 bps to 11.36% in 2024, then dropped by 3 bps to 11.05% in 2025, then tumbled by 70 bps to 3.34% in 2026.
• Business Quant data shows CNMD's FCF Margin at 3.34% in Q1 2026, 11.05% in Q4 2025, and 14.35% in Q3 2025.